RA CAPITAL MANAGEMENT, L.P. – Celldex Therapeutics, Inc. Transaction History
RA CAPITAL MANAGEMENT, L.P. portfolio value:
$58.32M
portfolio value
RA CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.38M | $28.11 | 2.07M | |
| Q2 2022 | share | 0.00% | 0 shares | -14.73M | $26.96 | 2.07M | |
| Q1 2022 | share | Increase | +14.97% | 270.20K shares | 938K | $34.06 | 2.07M |
| Q4 2021 | share | Increase | +12.80% | 204.79K shares | -16.64M | $38.9 | 1.80M |
| Q3 2021 | share | Increase | 0.00% | 1.6M shares | 86.38M | $53.99 | 1.6M |
| Q4 2020 | share | Decrease | -100.00% | -353.07K shares | -5.23M | $17.52 | 0 |
| Q3 2020 | share | Decrease | -69.30% | -796.92K shares | -9.71M | $14.83 | 353.07K |
| Q2 2020 | share | Increase | 0.00% | 1.15M shares | 14.95M | $13 | 1.15M |